Clinical Trial Update: Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE) [Phase 4]

View source ↗

Summary

Open-label Phase 4 study assessing belimumab added to standard therapy in Chinese pediatric participants with active systemic lupus erythematosus; the trial has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Systemic Lupus Erythematosus | Phase 4 | Status: COMPLETED | Results posted: 2025-07-23